Navigation Links
Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
Date:5/22/2009

CORAL GABLES, Fla., May 22 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced that on May 19, 2009 it was advised by The NASDAQ Stock Market(R) that, based on the Company's stockholders equity as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, the Company is no longer in compliance with the $10 million minimum stockholders' equity requirement for continued listing on the NASDAQ Global Market under NASDAQ Marketplace Rule 5450(b)(1)(A). As of March 31, 2009, the Company's stockholders' equity was approximately $7.7 million. This notification has no immediate effect on the Company's listing on the NASDAQ Global Market or on the trading of the Company's common stock.

As provided in the rules of The NASDAQ Stock Market, the Company has until June 3, 2009 to provide The NASDAQ Stock Market with a plan to regain compliance with the NASDAQ Global Market continued listing requirements. If The NASDAQ Stock Market accepts the Company's plan, of which there can be no assurance, The NASDAQ Stock Market may grant the Company up to 105 days from May 19, 2009 to achieve and sustain compliance. If The NASDAQ Stock Market determines that the Company's plan is not sufficient to achieve and sustain compliance, it will provide written notice that the Company's common stock will be delisted from the NASDAQ Global Market. At such time, the Company may appeal NASDAQ's delisting determination to a NASDAQ Listing Qualifications Panel or may apply to list its common stock on the NASDAQ Capital Market. The NASDAQ Capital Market is a continuous trading market that operates in the same manner as the NASDAQ Global Market. All companies whose securities are listed on the NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New fuel cell catalyst uses 2 metals
2. Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
3. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
4. Researchers create catalysts for use in hydrogen storage materials
5. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
6. Brown chemists create more efficient palladium fuel cell catalysts
7. New catalyst paves the path for ethanol-powered fuel cells
8. Coalition for the Advancement of Medical Research Releases New White Paper, Catalyst for Cures: Embryonic Stem Cell Research
9. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
10. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time
11. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , HOUSTON, Dec. 3 JourneyL...pdated its facility to offer patients a second sur... with the LAP-BAND® System that it currentl... at the facility was performed by surgeon partner,...e patient is reported as doing well. ,, The Ver...
(Date:12/3/2009)..., PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -...l specialty biopharmaceutical company, today annou... market withdrawal of one lot of the Attention-Def...® . Shire is taking this action because some ...not meet their release liner removal specification...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswi...ience Officer at Shenzhen Beike Biotechnology Co. ...conference on High-Risk Diabetic,Foot Care in New ...leading,stem cell research and regenerative medici...y the Indian Podiatry Association (IPA), aimed,to ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Carbond..., http://www.reportlinker.com/p0164368/Carbond...ml ,, Incubators are the most critical equipm...ch, and other applications for providing a control...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...nds Company Initial $250,000 under March ...ril 22 bioMETRX Inc., (OTC,Bulletin Board: BMRX),...d,finger-activated products, today announced that ...sets and former personnel of Sequiam,Corporation (...nounced,agreement with Biometric Investors, LLC., ...
...22 Renovis, Inc.,(Nasdaq: RNVS ), today announce... firm, has joined ISS/Risk Metrics in recommending...greement with Evotec AG (Frankfurt,Stock Exchange:...d for May,1, 2008. In the proposed merger, each sh... the right to receive the equivalent of 1.0542 Evo...
...rement helps physicians guide therapy for ...GHAM, Ala., April 22 The determination of LDL,non...e and recommended,methods of guiding and achieving...metabolic risk (CMR). The VAP(R) Cholesterol Test ...ble advanced lipid profile that routinely,reports ...
Other Biology Technology:bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp. 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 2Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec 3Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 2Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients 3
(Date:12/3/2009)...year record low in Antarctic snowmelt that occurre... to concurrent strong positive phases for two main...ion) and SAM (Southern Hemisphere Annular Mode), a... of Earth & Atmospheric Sciences at The City Colle...so on the doctoral faculty at the CUNY Graduate Ce...
(Date:12/2/2009)...LADELPHIA Less acculturated Latino men have a mor...re more acculturated to U.S. culture, but accultur...oking. Details of these findings are published in ...journal of the American Association for Cancer Res...obacco. , "Acculturation affects smoking cessati...
(Date:12/2/2009)...DELPHIA Cigarette smoking and alcohol consumption...edicts the patient,s future risk of death, accordi...dy show a similar effect among those who continued...ncer survivors are counseled to quit smoking; desp...nt continued to smoke even after their cancer diag...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Acculturation affects smoking cessation success among Latinos 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2The tourist trap 9540 1Capping a two faced particle gives duke engineers complete control 13514 1Capping a two faced particle gives duke engineers complete control 13514 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 1Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 2Fenwal and Golden Meditech Agree to Form Joint Venture in China for Blood Collection and Transfusion Technologies 13513 3
...s and a common heavy metal are unable to obtain su... according to a new study presented at The America...ysiology 2006. , The study showed how cadmium, a ...mer water temperatures and makes it more vulnerabl...Half of the oysters exposed to the pollutant in 28...
...apeutic drugs specifically targets mutant enzymes ...te uncontrolled cell growth. As promising as these...the wall have the tendency to fight back. A major ... of cellular desperation. , In a forthcoming issue...te for Biological Studies uncover one means cancer...
...differences among female Glanville fritillary butt...irth place and establish new colonies. These ventu...ce more quickly compared to their less mobile fema...ic differences influence behavior and how the envi...viduals with certain traits, said lead author Howa...
Other Biology News:Rising ocean temperatures, pollution have oysters in hot water 2Rising ocean temperatures, pollution have oysters in hot water 3Rising ocean temperatures, pollution have oysters in hot water 4Distinguishing friend from foe in the battle against cancer 2Distinguishing friend from foe in the battle against cancer 3Some butterflies travel farther, reproduce faster 2Some butterflies travel farther, reproduce faster 3
...and 135 S steam sterilizers with their ultra-flat ...he advantages of a double-walled device - low ener...ve deaeration and drying by built-in jacket heater...ng. The chamber is free of furnishings and feed wa...
...Console Orbital Shakers combine high durability an...alled programming power. The patented triple-coun...n, allowing the unit to run with heavy out-of-bala...duces contamination. The heavy stainless steel in...
SagaGT Microsatellite Analysis Software (Server edition) from LI-COR Biosciences
...rray CGH Genomic Labeling Systems are a high-perfo...ling of genomic DNA samples for array-based Compar...th indirect and direct labeling formats, the BioPr...e a flexible solution to your genomic labeling nee...
Biology Products: